Telomerase beyond telomeres

Nature Reviews Cancer

Volumn 2, Issue 8, 2002, Pages 627-632

  Blasco, María A ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TELOMERE; ANIMAL; ARTICLE; CELL DIVISION; GENETICS; HUMAN; NEOPLASM; PATHOLOGY;

ANIMALS; CELL DIVISION; HUMANS; MICE; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0036674425     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc862     Document Type: Review

References (45)

1. Blackburn, E. H. Switching and signaling at the telomere. Cell 106, 661-673 (2001).
2. Chan, S. W-L. & Blackburn, E. H. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21, 553-563 (2002).
3. De Lange, T. Protection of mammalian telomeres. Oncogene 21, 532-540 (2002).
4. Griffith, J. D. et al. Mammalian telomeres and in a large duplex loop. Cell 97, 503-514 (1999).
5. Ancelin, K. et al. Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol. Cell. Biol. 22, 3474-3487 (2002).
6. Karlseder, J., Smogorzewska, A. and de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science 295, 2446-2449 (2002).
7. Goytisolo, F. A. & Blasco, M. A. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene 21, 584-591 (2002).
8. Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
9. Espejel, S. et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21, 2207-2219 (2002).
10. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 31, 458-460 (1990).
11. Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene 21, 564-579 (2002).
12. Lee, H-W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574 (1998).
13. -/- mice with short telomeres. EMBO Rep. 2, 800-807 (2001).
14. Hemann, M. T., Strong, M. A., Hao, L. Y. and Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77 (2001).
15. Bodnar, A. G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
16. Hiyama, E. & Hiyama, K. Clinical utility of telomerase in cancer. Oncogene 21, 643-649 (2002).
17. Mattson, M. P., Fu, W. & Zhang, P. Emerging roles for telomerase in regulating cell differentiation and survival: a neuroscientist's perspective. Mech. Aging Dev. 122, 659-671 (2001).
18. González-Suárez, E. et al. Increased epidermal tumors and increased wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619-2630 (2001).
19. Reyes, M. et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625 (2001).
20. McEachern, M. J. & Blackburn, E. H. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376, 403-409 (1995).
21. Smogorzewska, A. et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20, 1659-1668 (2000).
22. Prescott, J. C. & Blackburn, E. H. Telomerase RNA template mutations reveal sequence-specific requirements for activation and repression of telomerase action at telomeres. Mol. Cell. Biol. 20, 2941-2948 (2000).
23. Herrera, E. et al. Disease states associated to telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960 (1999).
24. Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868 (1990).
25. de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10, 518-527 (1990).
26. Zhu, J., Wang, H., Bishop, M. and Blackburn, E. H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl Acad. Sci. USA 96, 3723-3728 (1999).
27. Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538 (1999).
28. GonzáJez-Suárez, E., Samper, E., Rores, J. M. & Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet. 26, 114-117 (2000).
29. Corey, D. R. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 21, 631-727 (2002).
30. Neidle, S. & Read, M. A. G-quadruplexes as therapeutic targets. Biopolymers 56, 195-208 (2001).
31. Damm, K. et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958-6968 (2001).
32. Blasco, M. A., Rizen, M., Greider, C. W. and Hanahan, D. Differential regulation of telomerase activity and its RNA component during multistage tumorigenesis. Nature Genet. 12, 200-204 (1996).
33. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E. & de Lange, T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765-3772 (1996).
34. González-Suárez, E., Flores, J. M. & Blasco, M. A. Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol. Cell. Biol. (in the press).
35. Artandi, S. E. et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl Acad. Sci. USA 99, 8191-8196 (2002).
36. Thomas, M. et al. Cooperation between hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells. Neoplasia (in the press).
37. Oh, H. et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl Acad. Sci. USA 98, 10308-11033 (2001).
38. Stampfer, M. R. et al. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor-β growth inhibition in p16INK4A(-) human mammary epithelial cells. Proc. Natl Acad. Sci. USA 98, 4498-4503 (2001).
39. Lu, C. L., Fu, W. & Mattson, M. P. Telomerase protects developing neurons against DNA damage-induced cell death. Dev. Brain Res. 131, 167-171 (2001).
40. Zhu, H., Fu, W. & Mattson, M. P. The catalytic subunit of telomerase protects neurones against amyloid β-peptide induced apoptosis. J. Neurochem. 75, 117-124 (2000).
41. Xiang, H. et al. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating Rb/E2F pathway. Oncogene 21, 3784-3791 (2002).
42. Liu, Y. et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10, 1459-1462 (2000).
43. Nikaido, R. et al. Presence of telomeric G-strand tails in the telomerase catalytic subunit Tert knockout mice. Genes Cells 4, 563-572 (1999).
44. Bailey, S. M., Conforth, M. N., Kurimasa, A., Chen, D. J. and Goodwin, E. H. Strand-specific postreplicative processing of mammalian telomeres. Science 293, 2462-2465 (2001).
45. Goytisolo, F. A. et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 192, 1625-1636 (2000).